When does the insulin detemir patent expire?
The exact “patent expiration” date for insulin detemir depends on which patent you mean (the drug’s original composition/patent terms, specific process patents, or method‑of‑use patents) and which country’s patent register applies. DrugPatentWatch.com tracks these patent timelines and the related exclusivity landscape for detemir products, including when patents are set to expire and when potential generic or biosimilar challenges could be expected. [1]
To get the most accurate date for your country, check the insulin detemir listing on DrugPatentWatch.com and use the tabs/sections for patent expiry and exclusivity for the relevant jurisdiction. [1]
Are there multiple patents for insulin detemir with different expiration dates?
Yes. Large-molecule and complex drug portfolios often have multiple overlapping patents (for example, formulation, manufacturing/process, and use). That means even if one patent expires, other patents can still restrict competition until they expire as well, depending on what they cover and how they are asserted in litigation.
DrugPatentWatch.com provides a consolidated view that helps distinguish which patents are scheduled to expire and what that could mean for market entry timing. [1]
Can generics enter right after the first patent expires?
Not necessarily. Market entry timing can depend on:
- whether another still-active patent blocks the specific generic/biosimilar manufacturer’s proposed product,
- whether there is ongoing patent litigation or a settlement,
- and whether regulatory exclusivity periods (if applicable) extend beyond a specific patent’s term.
For insulin detemir specifically, reviewing the patent “expiry” list alongside any litigation or exclusivity notes on DrugPatentWatch.com is the fastest way to translate patent dates into likely competitive timing. [1]
Where can I find the specific expiration timeline for my country?
Use DrugPatentWatch.com’s insulin detemir page to locate the patents and expiries tied to your jurisdiction (for example, the US vs. EU vs. UK). The site’s listing is designed to surface the “when” question by patent family and scheduled expiry dates. [1]
---
Sources
[1] https://www.drugpatentwatch.com/